Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Hypoxia 1

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 4pimonidazole 2TH 302 2pembrolizumab 1inositol trispyrophosphate 1gadobutrol 1fluoromisonidazole 1Tirapazamine 1Surgical Procedures, Operative 1Radiotherapy 1Propofol 1Pancreaticoduodenectomy 1Paclitaxel 1Ipilimumab 1Injections 1Gemcitabine 1Ethiodized Oil 1Cisplatin 1Blood Specimen Collection 1Biopsy 1AQ4N 14-methylbenzenesulfonic acid 13-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypoxia × 4-methylbenzenesulfonic acid × Gastrointestinal × Clear all
NCT04727034 2022-10-12

Efficacy and Safety of Remimazolam Tosylate for Sedation in Gastroscopy

RenJi Hospital

Phase NA Unknown
1,800 enrolled
Gastrointestinal

Hypoxia, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡